Lonza
Lonza is a healthcare manufacturing organization helping pharmaceutical, biotech and nutrition companies to bring their treatments to market. They help their customers to deliver new and innovative medicines that treat a wide range of diseases, allowing their patients to benefit from life-saving and life-enhancing treatments.
Latest Lonza Content
Product News
New Mid-Term Guidance 2024 – 2028 Supported by Ramp-Up of Growth Projects
At its Capital Markets Day in Visp (CH), Lonza shared a detailed update on its strategic priorities and provided new Mid-Term Guidance for 2024 to 2028.
Product News
Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer
Lonza, announced the extension of a collaboration with a major biopharmaceutical partner for the commercial-scale filling of ADCs.
Article
The Transformative Power of Insights in Biopharma Development: Why a Digital Backbone Matters
Digitalization underpins the biopharma industry’s endeavors to keep up with innovation and get life-changing therapeutics into the hands of patients as quickly as possible. This article explores how a digital backbone can help to realize the full potential of data and generate meaningful insights.
Product News
Lonza Further Extends Collaboration With Major Biopharmaceutical Partner for Manufacturing Antibody-Drug Conjugates
Extended long-term collaboration to provide significant additional bioconjugation capacity for commercialization of antibody-drug conjugates (ADCs) for use against hard-to-treat cancers.
Video
The MODA® Platform: Digitalizing Quality & Manufacturing
Learn how Lonza’s MODA® Platform can help you by facilitating paperless execution across manufacturing & QC processes.
Product News
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein Manufacture
Lonza has launched the TheraPRO® CHO Media System, a new cell culture platform that simplifies processes and optimizes productivity and protein quality when used with GS-CHO cell lines.
Product News
Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium To Accelerate Cell Therapy Development
Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium, a novel chemically defined medium developed to optimize CAR T-cell manufacture.
Industry Insight
Change Management’s Impact on Innovation in the Pharma QC Laboratory
Change management is becoming an increasingly important part of company culture. This article explores how effective change management can reap significant benefits.
Article
The Role of Smart Technology in Mitigating the Risk of Human Error and Improving Productivity in Pharmaceutical Quality Control
In this article, discover the role HPLC plays in ensuring regulatory compliance and reliability of throughput, and how labs can automate to eliminate errors and build reliability into their processes.
Product News
Fraunhofer IZI Selects Lonza’s MODA-ES® Solution To Digitalize Manufacturing Operations
Fraunhofer IZI intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza.
Advertisement
